₹818.65
+5.80 (+0.71%)
As of 18 Sept 2026, Aarti Pharmalabs Ltd share price is ₹818.65. The stock opened at ₹818.65 and had closed at ₹812.85 the previous day. Over the last 52 weeks, the stock has recorded a low of ₹583.85 and a high of ₹946.45. In terms of performance, Aarti Pharmalabs Ltd share price has increased by 24.03% over the past six months and has decreased by 12.62% over the last year.
AARTIPHARM Stock Price Chart
Aarti Pharmalabs Ltd Overview
Market cap₹7,424 Crs
Volume45,206
Prev. Close₹812.85
Year range₹583.85 - ₹946.45
ISININE0LRU01027
About AARTIPHARM
Aarti Pharmalabs engaged in the manufacture of Active Pharmaceutical Ingredients (API), Pharmaceutical Intermediates and Xanthine Derivatives in India.
Aarti Pharmalabs Ltd Historical Performance
1 Month Return-5.76%
6 Month Return29.34%
3 Year Return73.32%
3 Month Return27.23%
1 Year Return-10.83%
5 Year Return-
Aarti Pharmalabs Ltd Fundamentals
ROCE(TTM)10.13%
P/E Ratio (TTM)35.42
P/B Ratio3.72
Debt to Equity0.38
ROE8.89%
EPS (TTM)23.18
Dividend Yield0.43%
Book Value218.61
Profit Margin10.74%
Operating Margin16.28%
Aarti Pharmalabs Ltd Financials
| Indicator | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Revenue | 1,812.87 | 1,785.84 | 1,513.14 | 1,512.53 | 943.53 |
| EBITDA | 385.44 | 441.03 | 357.16 | 309.62 | 182.30 |
| Net Profit | 176.20 | 257.35 | 200.65 | 171.73 | 106.73 |
| EPS | 19.44 | 28.39 | 22.14 | 18.95 | 11.78 |
Aarti Pharmalabs Ltd Technical Analysis
| Indicator | Value |
|---|---|
| Support 1 (S1) | 779.00 |
| Resistance 1 (R1) | 832.70 |
| Pivot Point | 798.85 |
Aarti Pharmalabs Ltd Dividend History
| Ex Date | Dividends Date | Record Date | Dividend Type | Dividend Details |
|---|---|---|---|---|
| 15-Sep-2026 | 25-May-2026 | 15-Sep-2026 | Final | ₹2.00 |
| 16-Feb-2026 | 09-Feb-2026 | 16-Feb-2026 | Interim | ₹1.50 |
| 15-Sep-2025 | 10-May-2025 | 15-Sep-2025 | Final | ₹2.50 |
| 14-Feb-2025 | 05-Feb-2025 | 14-Feb-2025 | Interim | ₹2.50 |
| 31-Jul-2024 | 13-May-2024 | 31-Jul-2024 | Final | ₹1.00 |
AARTIPHARM Key Leadership Details
Last Updated: Mar 2025
| Name | Position |
|---|---|
| Chandrakant V Gogri | Chairman |
| Rashesh C Gogri | Chairman |
| Hetal Gogri Gala | Managing Director |
Aarti Pharmalabs Ltd Peer Comparison
| Company | Price | M.Cap (Cr) | P/E (TTM) | ROE (TTM) |
|---|---|---|---|---|
| Sun Pharmaceutical Industries LtdSUNPHARMA | ₹1,867.30+0.74% | ₹4,19,727.66 | 38.32 | 13.74% |
| Divis Laboratories LtdDIVISLAB | ₹9,323.00+1.80% | ₹1,67,235.91 | 67.46 | 15.32% |
| Torrent Pharmaceuticals LtdTORNTPHARM | ₹4,875.00+1.30% | ₹1,46,951.32 | 64.68 | 25.49% |
Disclaimer
The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...
Frequently Asked Questions
- The share price of Aarti Pharmalabs Ltd today is ₹818.65 on NSE and ₹818.65 on BSE.
- The 52-week high of Aarti Pharmalabs Ltd is ₹946.45, while the 52-week low is ₹583.85.
- The current market capitalisation of Aarti Pharmalabs Ltd is approximately ₹7,424 crore.
- The P/E (Price-to-Earnings) ratio of Aarti Pharmalabs Ltd is 28.78. The ratio may vary with changes in the share price and earnings.
- The P/B (Price-to-Book) ratio of Aarti Pharmalabs Ltd is 3.01. It compares the company’s market value with its book value and can provide an indication of how the market values the company relative to its net assets.
- To buy Aarti Pharmalabs Ltd shares, you first need to open a demat account before you can place an order. Here's the process:
• Open a demat account online using your PAN, Aadhaar and bank details.
• Add funds to your trading account via UPI or net banking.
• Search for AARTIPHARM on TradeMobi or the Anand Rathi web platform.
• Place your order
• Track your holdings in the portfolio section. - Over the past 3 years, Aarti Pharmalabs Ltd has delivered a return of approximately 73.32%. This return is based on the change in the share price over the specified period and may differ depending on the measurement date. Past performance does not guarantee future returns.
- The shareholding pattern of Aarti Pharmalabs Ltd comprises different categories of shareholders. As of Jun 2026, the shareholding is approximately 42.86% promoters, 7.38% FIIs, 7.22% DIIs, and 34.39% public shareholders.
Download TradeMobi App
- Real-Time Market Data
- Advanced Trading Tools
- Expert-Backed Research
